Tranexamic Acid recalls

The FDA has published 5 recalls involving Tranexamic Acid since 2014. The latest was reported on 21 Jun 2023. Most were for potency & assay. Fresenius Kabi USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls5since 2014
Last 12 months0reported
Class I120% of total
Ongoing2latest 21 Jun 2023

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 1 20%Class II 1 20%Class III 3 60%

Why tranexamic acid is recalled

By year

Ongoing tranexamic acid recalls

2 active
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIITranexamic Acid USP Tablets, 650 mg Unit Dose recalled by AVKARETranexamic AcidAVKAREPotency & AssayNationwide
DrugCLASS IIITranexamic Acid Injection, USP, 1000mg recalled by AuroMedics PharmaTranexamic AcidAuroMedics PharmaParticulate MatterNationwide

All tranexamic acid recalls, newest first

5 total

Should you stop taking Tranexamic Acid?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.